VIMZIPRUBART
UNII 34257Z97JJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Vimziprubart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 34257Z97JJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3084196-24-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

34257Z97JJ

CAS Registry Number

3084196-24-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VIMZIPRUBART

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

14158

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

Vimziprubart

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vimziprubart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Vimziprubart

Common Names & Synonyms

H-gamma1 heavy chain Homo sapiens (1-448) [VH (Homo sapiens IGHV3-23*04 (88.8%) -(IGHD) -IGHJ5*01 (90.9%) L123>Q (113), CDRIMGT[8.8.11] (26-33.51-58.97-107)) (1-118) -Homo sapiens IGHG1*01,G1m17,1 CH1 K120, CH3 D12, L14, 6-G1v14 CH2 A1.3, A1.2, 9-G1v21 CH2 Y15.1, T16, E18 (CH1 K120 (215) (119-216), hinge 1-15 (217-231),CH2 L1.3>A (235), L1.2>A (236), M15.1>Y (253), S16>T (255), T18>E(257) (232-341), CH3 D12 (357), L14 (359) (342-446), CHS (447-448))(119-448)], (221-214')-disulfide with L-kappa light chain Homo sapiens (1'-214') [V-KAPPA (Homo sapiens IGKV1-17*01 (95.8%) -IGKJ3*01 (100%),CDR-IMGT [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191'))(108'-214')]; dimer (227-227'':230-230'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa

Immunoglobulin G1 [235-alanine,236-alanine,253-tyrosine,255-threonine,257-glutamic acid], anti-(human OX40 ligand) (human-Mus musculus monoclonal AGP990 γ1-chain), disulfide with human-Mus musculus monoclonal AGP990 κ-chain, dimer

Immunoglobulin G1-kappa, anti-[Homo sapiens TNFSF4 (TNF superfamily member 4, tumor necrosis factor superfamily member 4, OX40 ligand, OX40L, TAX transcriptionally-activated glycoprotein 1, TXGP1, gp34, CD252)], Homo sapiens monoclonal antibody

vimziprubart [INN]

External Clinical & Regulatory Resources

Previous UNII3423KE0K4Y

Next UNII3426PF4EST